Moderna: mRNA Vaccine Is Only Viable In A COVID-Like Situation, Strong Sell

RSV and flu mRNA vaccines struggle with lower durability, higher side effects, and weak uptake, leading to program cuts and ...
Nanowerk

How dried mRNA vaccines could bypass cold chain storage requirements

Dried mRNA vaccines can match standard injection without cold storage when a polymer matrix at the right ratio prevents the ...

Moderna's mRNA flu vaccine is more effective than the standard shot in a late-stage trial

Moderna’s mRNA flu vaccine gave more protection against illness than the standard flu shot in a phase 3 clinical trial, ...

Personalized mRNA vaccine targets osteosarcoma relapse in first human use

In a breakthrough poised to reshape cancer treatment, Houston Methodist has developed the first personalized mRNA cancer ...

Moderna mRNA flu vaccine beats standard shot, awaits FDA review

After a large trial showed stronger protection, regulators are weighing whether Moderna’s mRNA vaccine could become a U.S.
University of California, San Francisco

This Anti-CRISPR Stops the Protein Assembly Line in Bacteria

Joe Bondy-Denomy solves a CRISPR caper: this is how a viral protein stows itself on protein factories in bacteria, and destroys a CRISPR protein, designed to kill viruses, while it's being made.

A new approach to cancer vaccination yields more powerful T cells

MIT engineers have developed a new way to amplify the T-cell response to mRNA vaccines—an advance that could lead to much more powerful cancer vaccines and stronger protection against infectious ...

Moderna, Inc. (MRNA) Presents at Bank of America Global Healthcare Conference 2026 Transcript

Bank of America Global Healthcare Conference 2026 May 12, 2026 2:20 PM EDTCompany ParticipantsLavina Talukdar - Senior VP & Head ...